Par Active Technologies Private Limited - Due diligence report

A 360° intelligence report on Parpharm: trust score, financial health, credit view, compliance, directors, growth and distress signals - gen…

2013-10-25 Chennai, Tamil Nadu Active Unlisted Active Compliant
Share
View plans Plan
PA Par Active Technologies Private Limited
View plans Plan
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Parpharm — 360° Intelligence Report

Generated from MCA filings & public records
80/100
Trust Score
Low Risk

Parpharm is assessed as Low Risk with a Trust Score of 80/100. Parpharm is an active private limited indian non-government company incorporated in 2013, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 10 Jul 2026 from the latest processed filings. Par Active Technologies Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
80/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
70/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
75/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 75/100 Low Risk
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 70/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • 2 auditor resignation(s) filed - latest: Price Waterhouse Chartered Accountants LLP on 2017-02-27.
  • Delayed payments to MSME suppliers disclosed (8 disclosure(s)).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
JAMES MATTHEW PAPP 01234567 Director 01/04/2018 6 yrs Approved
CHITTI BABU SAMPATH KUMAR 01234567 Director 01/04/2018 6 yrs Approved
ANAND AMRIT RAJ 01234567 Director 01/04/2018 6 yrs Approved
SATYENDRA NARAYAN DALABEHERA 01234567 Director 01/04/2018 6 yrs Approved
SATYENDRA NARAYAN DALABEHERA 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • SATYENDRA NARAYAN DALABEHERA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Par Formulations Private Limited
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 3 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Par Formulations Private Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +38% over 4 year(s).
Latest year revenue grew 1.42.
Profit expanded 2.1x year-on-year.
EPFO headcount growing - hiring signal.
Operating for 12+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
2 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 7.03 Lakh.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence79/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment78/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view90/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
26 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
30 Sep 2022
Director ceased
ANAND AMRIT RAJ
27 May 2022
Director appointed
ANAND AMRIT RAJ (Director)
Director ceased
JALAJ SHARMA
29 Nov 2021
Director ceased
JAMES MATTHEW PAPP
01 Oct 2021
Director appointed
SATYENDRA NARAYAN DALABEHERA (Company Secretary)
28 Jan 2021
Director appointed
JAMES MATTHEW PAPP (Director)
01 Dec 2020
Director ceased
RAHUL GARELLA
Director ceased
TERRANCE JOSEPH COUGHLIN
14 Aug 2020
Securities allotted
64444444 Equity Shares - 64.44 cr raised
01 Feb 2018
Director ceased
ROBERT JOSEPH COBUZZI JR
28 Sep 2017
Director ceased
CHITTI BABU SAMPATH KUMAR
28 Jun 2017
Director appointed
CHITTI BABU SAMPATH KUMAR (Director)
02 Mar 2017
Director ceased
SUSAN TERESA HALL
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - leverage worth monitoring.
Net worth is positive.
5 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Virgo Paints Private Limited U24222TN2009PTC072807 Chennai, Tamil Nadu, India
Arbee Aquatic Proteins Private Limited U15120KL2013PTC034002 Kottayam, Kerala, India
Banlab U24231GJ1986PTC008681 Rajkot, Gujarat, India
Yew Petroproducts Private Limited U24299WB2005PTC104774 Na, West Bengal, India
Vanu Chemicals Private Limited U24304DL2017PTC318549 New Delhi, Delhi, India
Kwalichem Private Limited U24304MH2020PTC349278 Mumbai, Maharashtra, India
Verdant Life Sciences U24232AP2008PTC059563 Parawada Mandal, Andhra Pradesh, India
Cs Fine Interchem Private Limited U24290GJ2019PTC109971 Vapi, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Parpharm before audits and certifications: compliance score 70/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Parpharm: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 75/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Parpharm - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 80/100, distress signals and MSME payment-delay disclosures - know whether Parpharm pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Parpharm - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Parpharm an active company?

Parpharm has MCA status “Active” with a compliance score of 70/100 (Moderate).

Is Parpharm financially healthy?

Parpharm has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Parpharm?

Its overall Trust Score is 80/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Parpharm?

The ultimate holding entity is Par Formulations Private Limited. 5 active director(s) are on record.

Does Parpharm have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Parpharm up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 70/100 (Moderate).

Is it risky to lend to Parpharm?

Its Credit Risk Score is 75/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.